CONMED (CNMD) PT Raised to $95 at Needham & Company

April 25, 2019 8:26 AM

Needham & Company analyst Mike Matson raised the price target on CONMED (NASDAQ: CNMD) to $95.00 (from $94.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found